| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/29/2005 | US6872525 Method for selectively separating live cells expressing a specific gene |
| 03/29/2005 | US6872524 Method of detecting an expression-enhancing sequence |
| 03/29/2005 | US6872523 Materials and methods for molecular detection of clinically relevant pathogenic fungal species |
| 03/29/2005 | US6872521 Polymerase signaling assay |
| 03/29/2005 | US6872520 Peptide for use in the detection of viral infection and diseases |
| 03/29/2005 | US6872517 Detection of tumors in mammalian gastrointestinal tract; incubate sample in detection solution, detect binding of preferential gastrointestinal proteins |
| 03/29/2005 | US6872398 Conjugate vaccine against gram-negative bacterial infections |
| 03/29/2005 | US6872391 Nucleotide sequences coding polypeptide for use in the treatment of eating disorders |
| 03/29/2005 | CA2225831C Novel detection methods for cryptosporidium |
| 03/29/2005 | CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 03/29/2005 | CA2139667C Methods and diagnostic kits for determining toxicity utilizing bacterial stress promoters fused to reporter genes |
| 03/26/2005 | CA2441695A1 Regulation of matrix metalloproteinases by psp94 family members |
| 03/25/2005 | CA2482093A1 Quantitation of nucleic acids using growth curves |
| 03/24/2005 | WO2005027015A2 Method and system for quantitatively analyzing biological samples |
| 03/24/2005 | WO2005026911A2 Apparatus and method for identifying therapeutic targets using a computer model |
| 03/24/2005 | WO2005026739A2 Increasing the bioavailability of carotenoids by enzymatic hydrolysis of the corresponding fatty acid esters |
| 03/24/2005 | WO2005026738A2 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a9 (slc22a9) |
| 03/24/2005 | WO2005026735A2 Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer |
| 03/24/2005 | WO2005026733A1 Method and device for detecting feline immunodeficiency virus |
| 03/24/2005 | WO2005026730A2 Multiplex binding and activity assays |
| 03/24/2005 | WO2005026692A2 Direct detection method for products of cellular metabolism using tof-sims |
| 03/24/2005 | WO2005026691A2 Detection of 13q14 chromosomal alterations |
| 03/24/2005 | WO2005026686A2 Multiplexed analytical platform |
| 03/24/2005 | WO2005026393A2 Biological particulate matter analogue |
| 03/24/2005 | WO2005026392A2 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 03/24/2005 | WO2005026391A1 Method for gene identification signature (gis) analysis |
| 03/24/2005 | WO2005026390A1 Dna detection method using molecular beacon with the use of monomer fluorescence/excimer fluorescence switching of fluorescent molecule |
| 03/24/2005 | WO2005026389A2 Ligation-based method of analysis of single nucleotide polymorphisms on genomic dna |
| 03/24/2005 | WO2005026387A1 A method for obtaining structural information concerning an encoded molecule and method for selecting compounds |
| 03/24/2005 | WO2005026386A1 Insulin-like growth factor-1 receptor (igf-1r) polymorphic alleles and use of the same to identify dna markers for reproductive longevity |
| 03/24/2005 | WO2005026385A1 Hormone receptor genes and migraine susceptibility |
| 03/24/2005 | WO2005026384A1 Methods of improving therapy for hiv infection |
| 03/24/2005 | WO2005026383A1 Method and device for determining if a product is in condition for use or consumption |
| 03/24/2005 | WO2005026382A1 Neural colony forming assay |
| 03/24/2005 | WO2005026381A2 Microarray analysis of host and pathogen gene expression changes in vivo |
| 03/24/2005 | WO2005026378A2 Methods for gene function analysis |
| 03/24/2005 | WO2005026377A2 Detection of nucleic acid sequences |
| 03/24/2005 | WO2005026376A2 Improved methods for sequencing gc-rich and cct repeat dna templates |
| 03/24/2005 | WO2005026374A2 Method for synthesizing nucleic acids, and application thereof |
| 03/24/2005 | WO2005026358A1 Polymorphisms in selenoprotein s |
| 03/24/2005 | WO2005026355A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026354A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026353A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026352A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026351A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026350A1 Method of evaluating cancerization degree |
| 03/24/2005 | WO2005026344A1 Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
| 03/24/2005 | WO2005026340A1 Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity |
| 03/24/2005 | WO2005026329A2 Methods for identifying target nucleic acid molecules |
| 03/24/2005 | WO2005026314A2 Group of genes differentially expressed in peripheral blood cells and diagnostic method and assay method using the same |
| 03/24/2005 | WO2005026313A1 Methods and device for adhesive control of internal cell organisation |
| 03/24/2005 | WO2005026205A2 Genetic products which are differentially expressed in tumours and use thereof |
| 03/24/2005 | WO2005026192A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005026191A2 Size-controlled macromolecule |
| 03/24/2005 | WO2005026184A2 Synthesis and compositions of 2'-terminator nucleotides |
| 03/24/2005 | WO2005026131A1 Transition state structure and inhibitors of thymidine phosphorylases |
| 03/24/2005 | WO2005025607A1 Methods of stimulating innate immunity using cationic peptides |
| 03/24/2005 | WO2005025602A1 METHODS FOR IDENTIFYING MODULATORS OF PROTEIN KINASE C-EPSILON (PKCϵ) AND METHOD OF TREATMENT OF ABERRANT GLUCOSE METABOLISM ASSOCIATED THEREWITH |
| 03/24/2005 | WO2005025591A2 CASPASE DERIVED CARDs |
| 03/24/2005 | WO2005025518A2 Inhibition of inward sodium currents in cancer |
| 03/24/2005 | WO2005025497A2 Hpv cd8+ t-cell epitopes |
| 03/24/2005 | WO2005025495A2 Methods and compositions for blocking progression of a disease state |
| 03/24/2005 | WO2005025409A2 Methods for risk assessment, survival prediction and treatment of heart failure and other conditions based on adrenergic receptor polymorphisms |
| 03/24/2005 | WO2005025408A2 Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence |
| 03/24/2005 | WO2005010492A3 Classification of disease states using mass spectrometry data |
| 03/24/2005 | WO2005010210A3 Determining the sequence of a polynucleotide |
| 03/24/2005 | WO2005010201A3 Methods and compositions for detecting nucleic acid sequences |
| 03/24/2005 | WO2005009581A3 Methods and apparatus for blood separation and analysis using membranes on an optical bio-disc |
| 03/24/2005 | WO2005009348A3 Substituted purine derivatives |
| 03/24/2005 | WO2005008213A3 Expression profile algorithm and test for cancer prognosis |
| 03/24/2005 | WO2005007893A3 Universal detection of binding |
| 03/24/2005 | WO2005003297A3 Mptens as modifiers of the pten/igf pathway and methods of use |
| 03/24/2005 | WO2005001140A3 Methods and nucleic acids for the analysis of colon cell proliferative disorders |
| 03/24/2005 | WO2005001124A3 Methods of nucleic acid analysis |
| 03/24/2005 | WO2005001026A3 Adks as modifiers of the pten pathway and methods of use |
| 03/24/2005 | WO2004111270A3 Differential gene expression in schizophrenia |
| 03/24/2005 | WO2004111259A3 Hydrolytic substrates for an analyte-dependent enzyme activation system |
| 03/24/2005 | WO2004111194A3 Method to increase protein production in culture |
| 03/24/2005 | WO2004111186A3 Monitoring for and detecting microbes used in bioterrorism |
| 03/24/2005 | WO2004109290A3 Methods for identifying modulators of kinesin activity |
| 03/24/2005 | WO2004105681A3 Cd4+ human papillomavirus (hpv) epitopes |
| 03/24/2005 | WO2004104229A3 Internal control nucleic acid molecule for nucleic acid amplification systems |
| 03/24/2005 | WO2004098509A3 Compositions for inducing immune responses |
| 03/24/2005 | WO2004097367A3 Chromogenic substrate with a ph indicator dye |
| 03/24/2005 | WO2004097030A3 Prognostic breast cancer biomarkers |
| 03/24/2005 | WO2004096986A3 Method for quantitative detection of nucleic acid molecules |
| 03/24/2005 | WO2004094673A3 Methods for monitoring drug activities in vivo |
| 03/24/2005 | WO2004092738A3 Assay for modulators of e2f-1 phosphorylation |
| 03/24/2005 | WO2004090169A3 Compositions for controlled release of enzymatic reaction components |
| 03/24/2005 | WO2004089187A3 Caries risk test for predicting and assessing the risk of disease |
| 03/24/2005 | WO2004087952A3 Genes regulated by hydrogen peroxide stress |
| 03/24/2005 | WO2004087894A3 Bacterial aggregates |
| 03/24/2005 | WO2004086949A3 Dna markers for management of cancer |
| 03/24/2005 | WO2004084815A3 Virulence genes of h. pylori in gastric cancer |
| 03/24/2005 | WO2004079333A3 Method and kit for extracting rna from sputum |
| 03/24/2005 | WO2004078941A3 Modulation of gene expression using dna-rna hybrids |
| 03/24/2005 | WO2004074503A3 Nucleic acid sequencing methods, kits and reagents |
| 03/24/2005 | WO2004072222A3 Method of preparing a collection of means for the detection of genes which can be induced by an inflammation mediator, and applications of same |
| 03/24/2005 | WO2004071269A3 Gene marker and composition for diagnosis and treatment of neurological disorders and diseases and use of the same |
| 03/24/2005 | WO2004069867A3 Genetic polymorphisms as predictive diagnostics for adverse drug reactions (adr) and drug efficacy |